Evaxion Biotech A/S
EVAX
$1.65
$0.063.77%
NASDAQ
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -27.05% | 6.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.00% | 1.50% | |||
| Operating Income | 24.26% | -1.50% | |||
| Income Before Tax | 19.96% | 0.61% | |||
| Income Tax Expenses | 8.76% | 13.78% | |||
| Earnings from Continuing Operations | 20.34% | 0.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.34% | 0.09% | |||
| EBIT | 24.26% | -1.50% | |||
| EBITDA | 23.33% | -0.63% | |||
| EPS Basic | 26.58% | 0.00% | |||
| Normalized Basic EPS | 26.22% | 0.53% | |||
| EPS Diluted | 26.58% | 0.00% | |||
| Normalized Diluted EPS | 26.22% | 0.53% | |||
| Average Basic Shares Outstanding | 8.49% | -0.09% | |||
| Average Diluted Shares Outstanding | 8.51% | -0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||